3 Stocks to Buy With Less Than $20

The article highlights three sub-$20 stocks—Rivian around $17, SoFi at 28.3x forward earnings, and Adyen around $11—as potential long-term opportunities despite recent headwinds. Rivian is contending with slowing EV demand but is preparing the R2 launch and a level 4 autonomy push, while SoFi faces weak results and a short-seller report but is still expanding its ecosystem. Adyen remains pressured by unimpressive results and guidance, though its large client base and high switching costs support a constructive long-term case.

Analysis

The setup is less about three cheap stocks and more about three different durations of optionality. RIVN is a classic call option on product/technology execution: if a lower-priced model lands and autonomy remains credible, the equity can re-rate violently because the market is pricing survival, not a normalized automotive margin structure. The second-order beneficiary is actually UBER if any autonomous fleet partnership proves real; it gains route density and supply without owning the hardware, while suppliers to EV platforms may see a delayed but meaningful volume inflection if consumer adoption broadens beyond premium EVs.

SOFI is the most crowded debate because the market is already applying a banking multiple to an asset-light fintech story before the earnings power is fully proven. The key question is not whether the franchise can grow, but whether deposit/loan economics can scale fast enough to compress valuation through time rather than through the share price. The contrarian read is that the selloff may be partially justified near term, but the embedded volatility creates a favorable asymmetric setup for investors who can tolerate a 6-18 month reset in sentiment.

ADYEY looks like the cleanest quality compounder of the three, but it is also the most macro-sensitive in the near term because payment volumes and merchant confidence are the first things to wobble when growth slows. The market appears to be extrapolating one weak guide into a permanent multiple impairment, which is usually too aggressive for an infrastructure-like payment platform with switching costs. The longer-term winner set includes large merchants that can keep payment economics centralized, while smaller processors and point-solution vendors are more exposed if clients rationalize vendors in a softer spend environment.

The consensus is missing that these names do not trade on the same clock: RIVN trades on milestone execution, SOFI on operating leverage and funding confidence, and ADYEY on renewal of growth expectations. That creates a useful relative-value framework rather than three standalone longs. The most attractive risk/reward is to buy weakness in the highest-quality business where the narrative damage is likely ahead of fundamentals, while treating the auto name as a binary catalyst trade rather than a core holding.

Key Decisions for Investors

• Long ADYEY on a 3-6 month horizon; use current weakness to build a starter position, targeting a re-rating if guidance stabilizes. Risk/reward is attractive because downside is tied to macro softness, while upside comes from multiple repair on even modest growth normalization.
• Buy SOFI only on a staged basis over 2-4 quarters, not all at once. Treat it as a long-duration compounding bet; if deposit growth and product penetration continue, the stock can de-risk, but near-term volatility can easily cut 15-25% from entry.
• Trade RIVN as a catalyst option: prefer a small common position or out-of-the-money calls into R2/autonomy milestones over a large outright long. This is high convexity, but any miss on execution can rapidly compress the equity to a lower survival multiple.
• Pair long ADYEY / short a weaker payments or small-cap fintech basket over 6 months. The thesis is that investors are over-penalizing quality recurring platforms while underestimating how quickly weaker processors lose pricing power in a slower spend environment.
• Use UBER as the cleaner second-order exposure to any autonomous fleet progress, but only if the partnership moves from narrative to tangible testing milestones. The upside is that it captures optionality without manufacturing risk; the risk is that the autonomy timeline slips and the equity gets no incremental credit.